Time.news – “From the data we have it emerges that vaccines are effective and will continue to protect the population even with a possible spread of the Omicron variant. “This was stated by the executive director of EMA, Emer Cooke, in a hearing in the Health Committee of the European Parliament on the Covid pandemic.
“But we know that the efficacy decreases with time, therefore the booster dose becomes fundamental“, he added.
“We know that viruses mutate and we are ready – continued Emer Cooke – Since last February we have created guidelines to allow companies to rapidly adapt vaccines if this will be necessary. And I believe we must be very careful now, we still don’t know if it is necessary“.
“We have to work even harder to increase the vaccination rate in the European Union especially in those Member States where these rates are dangerously low. This is particularly important as we learn more about the Omicron. ”The executive director of EMA stressed.
“I would like to assure you about the safety aspect, I think it is very important to remember this is the largest group of data ever collected on a drug or vaccine worldwide – concluded Cooke – the pharmacovigilance system is able to identify rare side effects and ensure that these are managed. So not only do we have a pharmacovigilance system that works very well but we can also act where necessary. “
.